MNSB — what changed in the latest 10-Q
A section-by-section comparison of MNSB's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-07 vs the prior 10-Q · 2026-05-08
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +40 | −10 | ~99 | 152 |
| Market risk (Item 3) | Text added/removed | +40 | −10 | ~99 | 151 |
| Controls & procedures | Text added/removed | +40 | −10 | ~99 | 151 |
| Legal proceedings | Text added/removed | +40 | −10 | ~99 | 151 |
| Risk factors | Text added/removed | +40 | −10 | ~99 | 151 |
| Other information | Text added/removed | +40 | −10 | ~99 | 150 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-07
For the Three Months Ended June 30, For the Three Months Ended June 30,
During the six months ended June 30, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the six months ended June 30, 2026, interest income on loans was impacted by $0.5 million in net reversals.
The Company monitors loan payments on modified loans on an ongoing basis to determine how the loan is performing under the modification and if the loan is considered to have a payment default. Of the loans modified during the 12 months prior to June 30, 2026 to borrowers experiencing financial diffi…
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Text removed vs the prior filing · source: 10-Q · 2026-05-08
During the three months ended March 31, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the three months ended March 31, 2026, interest income on loans was impacted by $0.4 million in net reversals.
The Company monitors loan payments on performing and non-performing loans on an ongoing basis to determine if a loan is considered to have a payment default. Of the loans modified during the 12 months prior to March 31, 2026 to borrowers experiencing financial difficulties, none were past due as of …
The Company uses derivative financial instruments (“derivatives”) primarily to assist customers with their risk management objectives. The Company classifies these items as free standing derivatives consisting of customer accommodation interest rate loan swaps (“interest rate loan swaps”). The Compa…
The following tables summarize key elements of the Company’s derivative instruments as of March 31, 2026 and December 31, 2025.
The Company is able to recognize fee income upon execution of the interest rate swap contract. The Company did not record any interest rate swap fee income for the three months ended March 31, 2026 or 2025.
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-08-07
For the Three Months Ended June 30, For the Three Months Ended June 30,
During the six months ended June 30, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the six months ended June 30, 2026, interest income on loans was impacted by $0.5 million in net reversals.
The Company monitors loan payments on modified loans on an ongoing basis to determine how the loan is performing under the modification and if the loan is considered to have a payment default. Of the loans modified during the 12 months prior to June 30, 2026 to borrowers experiencing financial diffi…
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Text removed vs the prior filing · source: 10-Q · 2026-05-08
During the three months ended March 31, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the three months ended March 31, 2026, interest income on loans was impacted by $0.4 million in net reversals.
The Company monitors loan payments on performing and non-performing loans on an ongoing basis to determine if a loan is considered to have a payment default. Of the loans modified during the 12 months prior to March 31, 2026 to borrowers experiencing financial difficulties, none were past due as of …
The Company uses derivative financial instruments (“derivatives”) primarily to assist customers with their risk management objectives. The Company classifies these items as free standing derivatives consisting of customer accommodation interest rate loan swaps (“interest rate loan swaps”). The Compa…
The following tables summarize key elements of the Company’s derivative instruments as of March 31, 2026 and December 31, 2025.
The Company is able to recognize fee income upon execution of the interest rate swap contract. The Company did not record any interest rate swap fee income for the three months ended March 31, 2026 or 2025.
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-08-07
For the Three Months Ended June 30, For the Three Months Ended June 30,
During the six months ended June 30, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the six months ended June 30, 2026, interest income on loans was impacted by $0.5 million in net reversals.
The Company monitors loan payments on modified loans on an ongoing basis to determine how the loan is performing under the modification and if the loan is considered to have a payment default. Of the loans modified during the 12 months prior to June 30, 2026 to borrowers experiencing financial diffi…
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Text removed vs the prior filing · source: 10-Q · 2026-05-08
During the three months ended March 31, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the three months ended March 31, 2026, interest income on loans was impacted by $0.4 million in net reversals.
The Company monitors loan payments on performing and non-performing loans on an ongoing basis to determine if a loan is considered to have a payment default. Of the loans modified during the 12 months prior to March 31, 2026 to borrowers experiencing financial difficulties, none were past due as of …
The Company uses derivative financial instruments (“derivatives”) primarily to assist customers with their risk management objectives. The Company classifies these items as free standing derivatives consisting of customer accommodation interest rate loan swaps (“interest rate loan swaps”). The Compa…
The following tables summarize key elements of the Company’s derivative instruments as of March 31, 2026 and December 31, 2025.
The Company is able to recognize fee income upon execution of the interest rate swap contract. The Company did not record any interest rate swap fee income for the three months ended March 31, 2026 or 2025.
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-07
For the Three Months Ended June 30, For the Three Months Ended June 30,
During the six months ended June 30, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the six months ended June 30, 2026, interest income on loans was impacted by $0.5 million in net reversals.
The Company monitors loan payments on modified loans on an ongoing basis to determine how the loan is performing under the modification and if the loan is considered to have a payment default. Of the loans modified during the 12 months prior to June 30, 2026 to borrowers experiencing financial diffi…
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Text removed vs the prior filing · source: 10-Q · 2026-05-08
During the three months ended March 31, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the three months ended March 31, 2026, interest income on loans was impacted by $0.4 million in net reversals.
The Company monitors loan payments on performing and non-performing loans on an ongoing basis to determine if a loan is considered to have a payment default. Of the loans modified during the 12 months prior to March 31, 2026 to borrowers experiencing financial difficulties, none were past due as of …
The Company uses derivative financial instruments (“derivatives”) primarily to assist customers with their risk management objectives. The Company classifies these items as free standing derivatives consisting of customer accommodation interest rate loan swaps (“interest rate loan swaps”). The Compa…
The following tables summarize key elements of the Company’s derivative instruments as of March 31, 2026 and December 31, 2025.
The Company is able to recognize fee income upon execution of the interest rate swap contract. The Company did not record any interest rate swap fee income for the three months ended March 31, 2026 or 2025.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-07
For the Three Months Ended June 30, For the Three Months Ended June 30,
During the six months ended June 30, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the six months ended June 30, 2026, interest income on loans was impacted by $0.5 million in net reversals.
The Company monitors loan payments on modified loans on an ongoing basis to determine how the loan is performing under the modification and if the loan is considered to have a payment default. Of the loans modified during the 12 months prior to June 30, 2026 to borrowers experiencing financial diffi…
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Text removed vs the prior filing · source: 10-Q · 2026-05-08
During the three months ended March 31, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the three months ended March 31, 2026, interest income on loans was impacted by $0.4 million in net reversals.
The Company monitors loan payments on performing and non-performing loans on an ongoing basis to determine if a loan is considered to have a payment default. Of the loans modified during the 12 months prior to March 31, 2026 to borrowers experiencing financial difficulties, none were past due as of …
The Company uses derivative financial instruments (“derivatives”) primarily to assist customers with their risk management objectives. The Company classifies these items as free standing derivatives consisting of customer accommodation interest rate loan swaps (“interest rate loan swaps”). The Compa…
The following tables summarize key elements of the Company’s derivative instruments as of March 31, 2026 and December 31, 2025.
The Company is able to recognize fee income upon execution of the interest rate swap contract. The Company did not record any interest rate swap fee income for the three months ended March 31, 2026 or 2025.
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-07
For the Three Months Ended June 30, For the Three Months Ended June 30,
During the six months ended June 30, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the six months ended June 30, 2026, interest income on loans was impacted by $0.5 million in net reversals.
The Company monitors loan payments on modified loans on an ongoing basis to determine how the loan is performing under the modification and if the loan is considered to have a payment default. Of the loans modified during the 12 months prior to June 30, 2026 to borrowers experiencing financial diffi…
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Total Allowance for Credit Losses on Off-Balance Sheet Credit Exposure
Text removed vs the prior filing · source: 10-Q · 2026-05-08
During the three months ended March 31, 2026, $0.2 million of accrued interest reversed in 2025 was recovered. For the three months ended March 31, 2026, interest income on loans was impacted by $0.4 million in net reversals.
The Company monitors loan payments on performing and non-performing loans on an ongoing basis to determine if a loan is considered to have a payment default. Of the loans modified during the 12 months prior to March 31, 2026 to borrowers experiencing financial difficulties, none were past due as of …
The Company uses derivative financial instruments (“derivatives”) primarily to assist customers with their risk management objectives. The Company classifies these items as free standing derivatives consisting of customer accommodation interest rate loan swaps (“interest rate loan swaps”). The Compa…
The following tables summarize key elements of the Company’s derivative instruments as of March 31, 2026 and December 31, 2025.
The Company is able to recognize fee income upon execution of the interest rate swap contract. The Company did not record any interest rate swap fee income for the three months ended March 31, 2026 or 2025.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice